On September 1, 2022 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported it will present posters at four upcoming U.S. and international medical conferences in September (Press release, Scynexis, SEP 1, 2022, View Source [SID1234618895]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

United States

Mycoses Study Group Education and Research Consortium (MSGERC) Biennial Meeting – September 7-9, 2022, Albuquerque, N.M.

Title: Outcomes of Oral Ibrexafungerp in Refractory Patients with Candida Infections from an Open-Label Study in Patients with Serious Fungal Infections (FURI)
Date: Friday, September 9
Time: 3:30 pm – 5:00 pm MDT
Presenter: Nkechi Azie, M.D.

Title: Outcomes of Oral Ibrexafungerp in the Treatment of 10 Patients with Candida auris Infections, from the CARES Study
Date: Friday, September 9
Time: 3:30 pm – 5:00 pm MDT
Presenter: Nkechi Azie, M.D.
World Anti-Microbial Resistance (AMR) Congress – September 7-9, 2022, National Harbor, Md.

Title: Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of CDC Urgent Threat Pathogen, Candida auris
Date: Wednesday, September 7, and Thursday, September 8
Time: 10:20 am EDT both days
Presenter: Thomas King, MS, MPH
International

International Immunocompromised Host Society (ICHS) – September 8-11, 2022, Basel, Switzerland

Title: Oral Ibrexafungerp Outcomes in Patients with Chronic Mucocutaneous Candidiasis (CMC)
Date: Saturday, September 10
Time: 10:00 am -10:30 am CEST
Presenters: Riina Rautemma-Richardson and Chris Eades, Manchester University
21st Congress of the International Society for Human and Animal Mycology (ISHAM) –September 20-24, 2022, New Delhi, India

Title: All-Cause Mortality in Patients with Invasive Candidiasis or Candidemia from an Interim Analysis of a Phase 3 Open-label Study (FURI)
Date: Wednesday, September 21
Time: 12:30 pm – 1:30 pm IST
Presenter: Juergen Prattes, M.D., Medical University of Graz

Title: Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)
Date: Wednesday, September 21
Time: 12:30 pm – 1:30 pm IST
Presenter: Juergen Prattes, M.D., Medical University of Graz

On September 1, 2022 Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, reported that the Company will be participating in and hosting one-on-one meetings at the following conferences during September (Press release, Aadi Bioscience, SEP 1, 2022, View Source [SID1234618894]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual BioPharma Conference, September 7-8, 2022, in Boston, MA
Morgan Stanley’s 20th Annual Global Healthcare Conference, September 12-14, 2022, in New York, NY
Neil Desai, Ph.D., Aadi Bioscience Founder and CEO, will take part in a 30-minute fireside chat on Wednesday, September 14th at 2:55 pm ET
A live webcast of the fireside chat will be available on the Investors & News page of the Company’s website
H.C. Wainwright’s 24th Annual Global Investment Conference, September 12-14, 2022, in New York, NY
A pre-recorded presentation will be available on the Investors & News page of the Company’s website on Monday, September 12 at 7:00 am ET
Ladenburg Thalmann’s 2022 Healthcare Conference, September 29, 2022, in New York, NY
Neil Desai, Ph.D., Aadi Bioscience Founder and CEO, will give a brief presentation followed by an analyst-led fireside chat from 9:00 am – 9:25 am ET
A live webcast of the presentation will be available on the Investors & News page of the Company’s website
Replays of webcasts will be available for approximately 30 days following each presentation.

On September 1, 2022 Ascendis Pharma A/S (Nasdaq: ASND) reported that the company is scheduled to participate in three upcoming investor conferences in September (Press release, Ascendis Pharma, SEP 1, 2022, View Source [SID1234618893]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details:

Event Citi’s 17th Annual BioPharma Conference
Location Boston, MA
Date Wednesday, September 7, 2022
Time 3:30-4:15 p.m. Eastern Time / 12:30-1:15 p.m. Pacific Time
Speaker(s) Scott Smith, Senior Vice President, Chief Financial Officer

Event 2022 Wells Fargo Healthcare Conference
Location Boston, MA
Date Thursday, September 8, 2022
Time 8:35-9:05 a.m. Eastern Time / 5:35-6:05 a.m. Pacific Time
Speaker(s) Scott Smith, Senior Vice President, Chief Financial Officer

Event Morgan Stanley 20th Annual Global Healthcare Conference
Location New York, NY
Date Tuesday, September 13, 2022
Time 1:30-2:00 p.m. Eastern Time / 10:30-11:00 a.m. Pacific Time
Speaker(s) Jan Mikkelsen, President and Chief Executive Officer and Scott Smith, Senior Vice President, Chief Financial Officer
A live webcast of the events will be available on the Investors & News section of the Ascendis Pharma website at View Source A webcast replay will also be available on this website shortly after conclusion of each event for 30 days.

On September 1, 2022 PTC Therapeutics, Inc. (NASDAQ: PTCT) reported that the company will present a company overview at the following conferences (Press release, PTC Therapeutics, SEP 1, 2022, View Source [SID1234618892]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 17th Annual Healthcare Conference
Thursday, Sept. 8, at 1:55 p.m. EDT

Morgan Stanley 20th Annual Global Healthcare Conference
Monday, Sept. 12, at 4:15 p.m. EDT

The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics’ website at View Source and will be archived for 30 days following the presentation. It is recommended that users connect to PTC’s website several minutes prior to the start of the webcast to ensure a timely connection.

On September 1, 2022 ALX Oncology Holdings Inc., ("ALX Oncology") (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, reported that management will participate in two upcoming investor conferences (Press release, ALX Oncology, SEP 1, 2022, View Source [SID1234618891]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual BioPharma Conference
Format: Investor meetings
Date: Wednesday, September 7
Location: Boston, MA

H.C. Wainwright 24th Annual Global Investment Conference
Format: Fireside chat with analyst, Swayampakula Ramakanth
Date: Monday, September 12
Time: 7:00 AM Eastern Time
Location: Virtual
Webcast link: Available here

A live webcast of the H.C. Wainwright fireside chat is available here and can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com and selecting Events under the News and Events tab. A replay of the webcast will be archived for up to 90 days following the fireside chat date.